Read More Pharma Industry News Novartis reports positive results for Aimovig in phase 2 episodic migraine trial Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong… bypharmanewsdailyOctober 4, 2020
